ProfileOfResearchers

Identified 3

1

TITLE: Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: The V-325 study group
AUTHORS: Jaffer A Ajani; Vladimir M Moiseyenko; Sergei Tjulandin; Alejandro Majlis; Manuel Constenla; Corrado Boni; Adriano Rodrigues; Miguel Fodor; Yee Chao; Edouard Voznyi; Cindy Marabotti; Eric Van Cutsem;
PUBLISHED: 2007, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 25, ISSUE: 22

INDEXED IN:

WOS

2

TITLE: Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: The V-325 study group
AUTHORS: Jaffer A Ajani; Vladimir M Moiseyenko; Sergei Tjulandin; Alejandro Majlis; Manuel Constenla; Corrado Boni; Adriano Rodrigues; Miguel Fodor; Yee Chao; Edouard Voznyi; Lucile Awad; Eric Van Cutsem;
PUBLISHED: 2007, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 25, ISSUE: 22

INDEXED IN:

WOS

3

TITLE: Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 study group
AUTHORS: Eric Van Cutsem; Vladimir M Moiseyenko; Sergei Tjulandin; Alejandro Majlis; Manuel Constenla; Corrado Boni; Adriano Rodrigues; Miguel Fodor; Yee Chao; Edouard Voznyi; Marie Laure Risse; Jaffer A Ajani;
PUBLISHED: 2006, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 24, ISSUE: 31

INDEXED IN:

WOS

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service